Hervé Gisserot given newly-created Asia Pacific role at GSK

22 November 2016

Experienced industry executive Hervé Gisserot is to become head of pharmaceuticals for the newly-created Asia Pacific Region at UK pharma major GlaxoSmithKline (LSE: GSK).

Mr Gisserot is currently the senior vice president and general manager for China/Hong Kong pharmaceuticals and vaccines at GSK, and his new role will lead him to relocate from Shanghai to Singapore from January 1, 2017.

The new Asia Pacific Region will include all markets currently in the Asia Pacific Area plus China and Hong Kong. Mr Gisserot, who has been with GSK for more than eight years after a decade working for French pharma major Sanofi (Euronext: SAN), will continue to report to Abbas Hussain, president of global pharmaceuticals.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK